US2017216369A1PendingUtilityA1

Wound healing compositions involving medicinal honey, mineral ions and methylglyoxal, and methods of use

Individually held — no corporate assignee on recordPriority: Jan 29, 2015Filed: Oct 26, 2016Published: Aug 3, 2017
Est. expiryJan 29, 2035(~8.5 yrs left)· nominal 20-yr term from priority
A61P 31/00A61P 29/00A61P 17/02A61K 31/11A61K 35/644A61L 15/46A61L 2300/404A61L 2300/216A61L 15/40A61L 26/0057A61K 33/06A61K 33/30A61K 33/00A61K 33/04A61K 9/0014A61L 15/20A61K 31/121A61L 26/0066A61L 2300/30A61L 2300/102
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides compositions based on either medicinal honey containing broad spectrum antibacterial activities of peroxide, polyphenols and methylglyoxal, or an effective amount of an active anti-inflammatory ingredient of mineral solids fortified with methylglyoxal antibacterial activity, or a mixture of both for the treatment of wounds; and methods of treating a wound, comprising contacting a wound with any one of the above compositions or a wound dressing containing any one of the above compositions.

Claims

exact text as granted — not AI-modified
1 . A wound healing composition, comprising:
 a medicinal honey; and   a concentration of methylglyoxal being added to said medicinal honey effective to reduce a number of viable microorganisms at a wound site.   
     
     
         2 . The wound healing composition of  claim 1 , wherein the medicinal honey naturally contains or generates 2-4 mM hydrogen peroxide upon dilution with an aqueous medium. 
     
     
         3 . The wound healing composition of  claim 1 , wherein the medicinal honey naturally contains a polyphenol concentration ranging between 275 and 575 gallic acid equivalents per gram of the medicinal honey. 
     
     
         4 . The composition of  claim 1 , wherein the medicinal honey is buckwheat honey. 
     
     
         5 . The composition of  claim 1 , wherein said concentration of methylglyoxal ranges from 500 to 2000 mg per kg. 
     
     
         6 . The wound healing composition of  claim 1 , wherein the wound healing composition is replaced on a wound at least once. 
     
     
         7 . A wound healing composition, comprising:
 a pharmaceutically acceptable carrier;   an effective amount of an active ingredient of mineral solids, said mineral solids including at least one of a magnesium salt, a potassium salt, a calcium salt, a zinc salt, a rubidium salt, a bromide salt, and a sulfate salt; and   a concentration of methylglyoxal effective to reduce a number of microorganisms at a wound site being added to said active ingredient.   
     
     
         8 . The wound healing composition of  claim 7 , wherein each of the salts includes a pharmaceutically-acceptable counterion. 
     
     
         9 . The wound healing composition of  claim 7 , wherein the active ingredient of mineral solids includes 1.5-75 parts of magnesium ions, 0.5-75 parts of potassium ions, 0.001-10 parts of calcium ions, 0.0001-10 parts of zinc ions, up to 5 parts of rubidium ions, 0.001-20 parts of bromide ions, and up to 20 parts of sulfate ions, said parts expressing a mass of a respective ions divided by a total mass of the mineral solids. 
     
     
         10 . The wound healing composition of  claim 7 , wherein said methylglyoxal added to said active ingredient ranges from 500 to 2000 mg/kg of the composition. 
     
     
         11 . The wound healing composition of  claim 7 , wherein the pharmaceutically-acceptable carrier includes at least one of water, polyethylene glycol, an ointment, and a cream base. 
     
     
         12 . The wound healing composition of  claim 7 , wherein a pH of the composition is between 3.0-7.0. 
     
     
         13 . The wound healing composition of  claim 7 , wherein the wound healing composition is replaced on a wound at least once. 
     
     
         14 . A wound healing composition, comprising:
 a first would healing composition, including:
 a medicinal honey; and 
 a concentration of methylglyoxal being added to said medicinal honey effective to reduce a number of viable microorganisms at a wound site; 
   a second wound healing composition, including:
 a pharmaceutically acceptable carrier; 
 an effective amount of an active ingredient of mineral solids, said mineral solids including at least one of a magnesium salt, a potassium salt, a calcium salt, a zinc salt, a rubidium salt, a bromide salt, and a sulfate salt; and 
 a concentration of methylglyoxal effective to reduce a number of microorganisms at a wound site being added to said active ingredient; and 
 a ratio of a volume of said first wound healing composition to a volume of said second wound healing composition being between 1:9 and 9:1. 
   
     
     
         15 . A wound healing dressing, comprising:
 the wound healing composition according to  claim 1 ; and   a support.   
     
     
         16 . A wound healing dressing, comprising:
 the wound healing composition according to  claim 7 ; and   a support.   
     
     
         17 . A wound healing dressing, comprising:
 the wound healing composition according to  claim 14 ; and   a support.   
     
     
         18 . The wound healing dressing of  claim 15 , wherein the support includes at least one of a fibrous gauze material, a hydrogel, a foam, a film, a hydrocolloid, a collagen, and an alginate. 
     
     
         19 . A method of treating a wound, which comprises contacting a wound with the composition of  claim 1 . 
     
     
         20 . A method of treating a wound, which comprises contacting a wound with the wound dressing of  claim 15 . 
     
     
         21 . The wound healing composition of  claim 14 , wherein the wound healing composition is replaced on a wound at least once.

Join the waitlist — get patent alerts

Track US2017216369A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.